Thymosin α1 Thymosin Alpha 1 Thymalfasin CAS 62304-98-7 for Gym Bo

  Thymosin α1 Thymosin Alpha 1 Thymalfasin CAS 62304-98-7  

Basic Information

Thymalfasin (thymosin-α1) is an immunomodulatory agent that is able to augment some specific T lymphocyte functions, particularly that of promoting the T helper 1 cell responses involved in host antiviral defence. The most promising clinical applications for thymalfasin seem to be as a single agent for the treatment of chronic hepatitis B and in combination with interferon-α for the treatment of both chronic hepatitis B and C. These positive preliminary results offer a strong rationale for larger, well-planned clinical trials and also for defining the optimal schedule of administration.

Product Name: Thymosin α1 
Cas No: 62304-98-7
Formula: C129H215N33O55
Molecular:3108.3
Sequence:Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-                         Glu-Asn-OH
Purity:98%
Appearance: white powder
Source: synthetic
 

APPLICATION&FUNCTION

1. For the treatment of chronic hepatitis B.

2. A vaccine immune response enhancer as an immunocompromised patient. Immune system function is inhibited, including chronic hemodialysis and elderly patients, this product can enhance the immune response of patients with viral vaccines, such as influenza vaccine or hepatitis B vaccine.

A number of in vitro tests showed that the goods through the stimulation of peripheral blood lymphocytes promoting T lymphocyte mitogen original maturity, increase antigen or mitogen-activated T cells secrete interferon-α, interferon-γ and interleukin-2, interleukin-3, etc. lymphokines level, while increasing the T cell surface receptor level lymphokines. This product can also through the activation of CD4 cells, enhancing human allogeneic and autologous mixed lymphocyte reaction. It can be used to increase NK cells before aggregation, and enhanced cytotoxicity interferon can make it. In vivo tests showed that product can increase by Con A activated lymphocytes in mice interleukin-2 receptor expression levels, while increasing the secretion of interleukin-2 levels.
 

Why choose us :
The quality of our support is unmatched, We focus on the quality of our services. We're passionate about what we do. We welcome and act on your feedback. Proven track record. We provide a high level of support. We Guarantee Our Uptime, Support, and Services. Our Support Team is Friendly, Fast, and Knowledgeable. Our Customers Are Our Biggest Asset. Attention to Detail. AND OWN FACTORY OVER 10 YEARS~!!!!!!!!!!!!!!!!!!

 

About Us:

 ZhejiangHuajunPharmaceutical Co., Ltd., ( hereinafter calledHuajunpharma) a holding subsidiary of ZhejiangHuadiPharmaceutical Group Co., Ltd., was established in December 2015 with a registered capital of 50 millionyuan. In line with the tenet
of people-oriented, health promotion,HuajunPharmais mainly engaged in the research and development, production and sales ofnew products in the field of biopharmaceuticals. In November 2018,HuajunPharmawas recognized as a high-tech enterprise.

Huajunpharmafocuses on the production of synthetic peptide APIs,customized peptides, biochemical extracts and multi-componentbiochemical drugs. The representative products of synthetic peptides include:thymopentin, oxytocin,octreotide,Lanreotide,Leuprorelinetc. Biochemical extraction products include:Cerebroproteinhydrolysate, Ribonucleic acid,Thymosinpeptide,Chymotrypsin, Hepatocyte growth promoting factor (suckling pig liver extract), etc.


Huajunpharmahas Chinese GMP production line and R&D Center for synthetic polypeptide raw materials. It's also equipped withplant, equipment/facilities, storage area, air conditioning purification system and purified water preparation system which is suitable fordrug production. And there are trained and qualified production personnel, inspectors with technical ability to meet the productionrequirements.

Contact Us

Email: jayjie@hjyy.com

Whatsappp/Mobile: 008613675847137